Very rare cases of hypersensitivity reactions, including anaphylaxis and rash, have been reported during the marketing of desloratadine. In addition, cases of tachycardia, palpitations, seizures, psychomotor hyperactivity, somnolence, elevated liver enzymes and bilirubin, hepatitis, and increased appetite have been reported very rarely.
View ADR Reporting Link